This is a the United States news story, published by Yahoo, that relates primarily to Emma Walmsley news.
For more the United States news, you can click here:
more the United States newsFor more Emma Walmsley news, you can click here:
more Emma Walmsley newsFor more vaccine development news, you can click here:
more vaccine development newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like this article about vaccine development, you might also like this article about
shingles. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Shingrix news, blockbuster vaccines news, news about vaccine development, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
largest vaccine manufacturersReuters
•79% Informative
GSK said co-administration of its respiratory syncytial virus vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
RSV causes over 177,000 hospitalizations and 14,000 deaths in the United States annually .
GSK under CEO Emma Walmsley has focussed on vaccines and infectious diseases.
VR Score
89
Informative language
96
Neutral language
37
Article tone
formal
Language
English
Language complexity
74
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links